Cargando…
Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model
Celecoxib, a selective cyclooxygenase-2 inhibitor, has shown potential anticancerous activity against majority of solid tumors especially on patients with colon cancer. However, associations of serious side effects limit the usage of celecoxib in colon cancer treatment. To address this issue and pro...
Autores principales: | Perumal, Venkatesan, Banerjee, Shubhadeep, Das, Shubasis, Sen, R. K., Mandal, Mahitosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451972/ https://www.ncbi.nlm.nih.gov/pubmed/26069486 http://dx.doi.org/10.1007/s12645-011-0017-5 |
Ejemplares similares
-
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling
por: Kumar, B N Prashanth, et al.
Publicado: (2013) -
Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib
por: Moghimipour, Eskandar, et al.
Publicado: (2015) -
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
por: Singh, Sanjay
Publicado: (2018) -
Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation
por: Begum, M. Yasmin, et al.
Publicado: (2022) -
Effect of constant light on DMBA mammary tumorigenesis in rats
por: Anderson, L.E., et al.
Publicado: (2000)